Registered Uganda · NDA

R21 MALARIA VACCINE (RECOMBINANT, ADJUVANTED)

NDA/MAL/HDP/11230 PARENTERAL ORDINARY VIALS 5µG OF MALARIA ANTIGEN & 50µG OF MATRIX-M1 PER DOSE OF 0.5ML

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
NDA/MAL/HDP/11230
Registration date
22/03/2024
Expiry date
-
Status
Registered
Active ingredient
-
Dosage form
PARENTERAL ORDINARY VIALS
Strength
5µG OF MALARIA ANTIGEN & 50µG OF MATRIX-M1 PER DOSE OF 0.5ML
Pack size
1.0X50.0X0.5 ML VIAL (1 DOSE), 1.0X50.0X1.0 ML VIAL (2 DOSE)
Therapeutic class
-
Manufacturer / MAH
Serum Institute Of India Pvt Ltd
Applicant / LTR
SERUM INSTITUTE OF INDIA PVT LTD
Country of origin
INDIA
Manufacturer location
Serum Institute Of India, 212/2, off Soli Poonawalla Road, Parijat Colony, Sadhana Society, Hadapsar, Pune, Maharashtra 411028, India

Source: National Drug Authority · fetched 2026-04-21 17:37:05 · updated 2026-09-12 04:00:20

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.